SEC Filings for Dr. Reddy's Laboratories Ltd (RDY)

$ 51.89   -0.37 (-0.71%) Volume: 225.82k 7:00 PM EDT Jul 9, 2020
Filing Type:
Form TypeForm DescriptionPagesDateView
20-FRegistration statement / Annual report / Transition report23207/18/2012
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934407/05/2012
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934706/06/2012
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19341005/16/2012
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934405/08/2012
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934504/04/2012
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19345403/19/2012
6-K/A[Amend] Report of foreign issuer [Rules 13a-16 and 15d-16]1102/09/2012
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19341002/06/2012
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934402/01/2012
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19346012/12/2011
212223242526272829303132333435